Christine Densmore, M.S., Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) talks about SBIR/STTR and the NIDDK: Overview and R&D Interests at the 14th Annual Non-Dilutive Funding Summit.
Debkishore Mitra, PhD., Co-Founder and Chief Technological Officer, Diassess, shares his experience on Diassess’s successful non-dilutive funding journey at the 14th Annual Non-Dilutive Funding Summit.
Dr Dana Larocca, Vice President of Discovery Research, AgeX Inc. shares her story on how AgeX obtained Initial non-dilutive funding for their programs at the 14th Annual Non-Dilutive Funding Summit.
Ayal Ronen of the FreeMind Group gave a demonstration of a new shared work space we have developed and how it is propelling grant writing into the digital age.
View Slide Deck
Dr. Charles Cywin of the National Institute of Neurological Disorders and Stroke spoke about the programs available to support neuroscience translational research.
View Slide Deck
Dr. Matthew Portnoy of the National Institutes of Health gave updates on the Small Business Innovation Research and Small Business Technology Transfer Programs.
View Slide Deck
Dennis Ford of Life Science Nation shared tips on interacting with investors as you work on a strategic method of fundraising for your R&D.
View Slide Deck
John Nobile of Tangen Biosciences talked about his company’s process in achieving their recent contract with BARDA.
Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures.
View Slide Deck
Website Links
Address
FreeMind Group
6 Liberty Square #2783
Boston, MA 02109